Eva E Mörwald1,2, Ashley Olson3, Crispiana Cozowicz1,2, Jashvant Poeran3, Madhu Mazumdar3, Stavros G Memtsoudis4,5,6. 1. Department of Anesthesiology, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, USA. 2. Perioperative Medicine and Intensive Care Medicine, Paracelsus Medical University, Salzburg, Austria. 3. Institute for Healthcare Delivery Science, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 4. Department of Anesthesiology, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, USA. memtsoudiss@hss.edu. 5. Perioperative Medicine and Intensive Care Medicine, Paracelsus Medical University, Salzburg, Austria. memtsoudiss@hss.edu. 6. Department of Anesthesiology, Hospital for Special Surgery, 535 E 70th Street, New York, NY, 10021, USA. memtsoudiss@hss.edu.
Abstract
PURPOSE: Obstructive sleep apnea (OSA) has been linked to higher rates of perioperative complications. Practice guidelines recommend minimizing opioids in this cohort to reduce complications. However, a paucity of evidence exists relating different levels of opioid prescription to perioperative complications. Our aim was to investigate if different levels of opioid prescription are related to perioperative complication risk in patients with OSA. METHODS: A total of 107,610 OSA patients undergoing total knee or hip arthroplasty between 2006 and 2013 were identified in a nationwide database and divided into subgroups according to the amount of opioids prescribed. We then compared those subgroups for odds of perioperative complications using multilevel multivariable logistic regression models. RESULTS: OSA patients with higher levels of opioid prescription had increased odds for gastrointestinal complications (OR 1.90, 95% CI 1.47-2.46), prolonged length of stay (OR 1.64, 95% CI 1.57-1.72), and increased cost of care (OR 1.48, 95% CI 1.40-1.57). However, we found lower odds for pulmonary complications (OR 0.85, 95% CI 0.74-0.96) for the high-prescription group. CONCLUSIONS: Higher levels of opioid prescription were associated with higher odds for gastrointestinal complications and adverse effects on cost and length of stay but lower odds for pulmonary complications in OSA patients undergoing joint arthroplasties. The latter finding is unlikely causal but may represent more preventive measures and early interventions among those patients. Attempts to reduce opioid prescription should be undertaken to improve quality and safety of care in this challenging cohort in the perioperative setting.
PURPOSE:Obstructive sleep apnea (OSA) has been linked to higher rates of perioperative complications. Practice guidelines recommend minimizing opioids in this cohort to reduce complications. However, a paucity of evidence exists relating different levels of opioid prescription to perioperative complications. Our aim was to investigate if different levels of opioid prescription are related to perioperative complication risk in patients with OSA. METHODS: A total of 107,610 OSA patients undergoing total knee or hip arthroplasty between 2006 and 2013 were identified in a nationwide database and divided into subgroups according to the amount of opioids prescribed. We then compared those subgroups for odds of perioperative complications using multilevel multivariable logistic regression models. RESULTS: OSA patients with higher levels of opioid prescription had increased odds for gastrointestinal complications (OR 1.90, 95% CI 1.47-2.46), prolonged length of stay (OR 1.64, 95% CI 1.57-1.72), and increased cost of care (OR 1.48, 95% CI 1.40-1.57). However, we found lower odds for pulmonary complications (OR 0.85, 95% CI 0.74-0.96) for the high-prescription group. CONCLUSIONS: Higher levels of opioid prescription were associated with higher odds for gastrointestinal complications and adverse effects on cost and length of stay but lower odds for pulmonary complications in OSA patients undergoing joint arthroplasties. The latter finding is unlikely causal but may represent more preventive measures and early interventions among those patients. Attempts to reduce opioid prescription should be undertaken to improve quality and safety of care in this challenging cohort in the perioperative setting.
Authors: Jeffrey B Gross; Kenneth L Bachenberg; Jonathan L Benumof; Robert A Caplan; Richard T Connis; Charles J Coté; David G Nickinovich; Vivek Prachand; Denham S Ward; Edward M Weaver; Lawrence Ydens; Song Yu Journal: Anesthesiology Date: 2006-05 Impact factor: 7.892
Authors: Christopher M Bernards; Susan L Knowlton; Douglas F Schmidt; William J DePaso; Matthias K Lee; Susan B McDonald; Oneil S Bains Journal: Anesthesiology Date: 2009-01 Impact factor: 7.892
Authors: Anthony G Doufas; Lu Tian; Kevin A Padrez; Puntarica Suwanprathes; James A Cardell; Holden T Maecker; Periklis Panousis Journal: PLoS One Date: 2013-01-29 Impact factor: 3.240
Authors: Stavros G Memtsoudis; Crispiana Cozowicz; Mahesh Nagappa; Jean Wong; Girish P Joshi; David T Wong; Anthony G Doufas; Meltem Yilmaz; Mark H Stein; Megan L Krajewski; Mandeep Singh; Lukas Pichler; Satya Krishna Ramachandran; Frances Chung Journal: Anesth Analg Date: 2018-10 Impact factor: 5.108